PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34168412-0	2021	Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome.	Tacrolimus	77-87	albumin	Homo sapiens	12-19	
34168412-2	2021	AIM: To examine serum albumin (Alb) level as a prognostic factor for the therapeutic effect of tacrolimus in clinical practice.	Tacrolimus	95-105	albumin	Homo sapiens	22-29	
34168412-2	2021	AIM: To examine serum albumin (Alb) level as a prognostic factor for the therapeutic effect of tacrolimus in clinical practice.	Tacrolimus	95-105	albumin	Homo sapiens	31-34	
34168412-8	2021	In the Kaplan-Meier analysis, a week 2/week 0 Alb ratio <= 1 had a significantly higher failure rate than that of > 1; Cox proportional hazard regression analysis also showed that a week 2/week 0 Alb ratio <= 1 was an independent prognostic factor for failure within 3 mo after the start of tacrolimus treatment.	Tacrolimus	291-301	albumin	Homo sapiens	46-49	
34168412-8	2021	In the Kaplan-Meier analysis, a week 2/week 0 Alb ratio <= 1 had a significantly higher failure rate than that of > 1; Cox proportional hazard regression analysis also showed that a week 2/week 0 Alb ratio <= 1 was an independent prognostic factor for failure within 3 mo after the start of tacrolimus treatment.	Tacrolimus	291-301	albumin	Homo sapiens	196-199	
34168412-9	2021	CONCLUSION: A week 2/week 0 Alb ratio <= 1 predicts failure within 3 mo of tacrolimus administration for UC.	Tacrolimus	75-85	albumin	Homo sapiens	28-31	
25681723-0	2015	Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.	Tacrolimus	51-61	albumin	Homo sapiens	7-20	
25681723-2	2015	Tacrolimus (TAC)-loaded bovine serum albumin (BSA) nanoparticles (TAC-BSA-NPs) were prepared by emulsification-dispersion technique.	Tacrolimus	0-10	albumin	Homo sapiens	31-44	
34377239-14	2021	CONCLUSION: The combination of ultra-low dose rituximab and low dose tacrolimus is more effective in inducing proteinuria response, improving eGFR and serum albumin in non-responsive iMN patients than standard tacrolimus monotherapy.	Tacrolimus	69-79	albumin	Homo sapiens	151-164	
29330784-12	2018	A multivariate analysis of variance revealed that the tacrolimus concentration in oral fluids is related to the tacrolimus concentration in whole blood and tacrolimus plasma-binding proteins including albumin and cholesterol.	Tacrolimus	54-64	albumin	Homo sapiens	201-208	
29330784-12	2018	A multivariate analysis of variance revealed that the tacrolimus concentration in oral fluids is related to the tacrolimus concentration in whole blood and tacrolimus plasma-binding proteins including albumin and cholesterol.	Tacrolimus	112-122	albumin	Homo sapiens	201-208	
29330784-12	2018	A multivariate analysis of variance revealed that the tacrolimus concentration in oral fluids is related to the tacrolimus concentration in whole blood and tacrolimus plasma-binding proteins including albumin and cholesterol.	Tacrolimus	112-122	albumin	Homo sapiens	201-208